Order Article Reprints

Koeller DR, Walker M, Unal B, Chittenden A, Levine AS, Hayes CP, Oramasionwu PC, Manam MD, Buehler RM, Gomy I, et al. Advancing the Landscape of Clinical Actionability in Von Hippel–Lindau Syndrome: An Evidence-Based Framework from the INT²GRATE Oncology Consortium. Cancers. 2025; 17(13):2173. https://doi.org/10.3390/cancers17132173

Koeller, Diane R., McKenzie Walker, Busra Unal, Anu Chittenden, Alison Schwartz Levine, Connor P. Hayes, Paul C. Oramasionwu, Monica D. Manam, Ryan M. Buehler, Israel Gomy, and et al. 2025. "Advancing the Landscape of Clinical Actionability in Von Hippel–Lindau Syndrome: An Evidence-Based Framework from the INT²GRATE Oncology Consortium" Cancers 17, no. 13: 2173. https://doi.org/10.3390/cancers17132173

Koeller, D. R., Walker, M., Unal, B., Chittenden, A., Levine, A. S., Hayes, C. P., Oramasionwu, P. C., Manam, M. D., Buehler, R. M., Gomy, I., Silva, W. A., Jr., Lerner-Ellis, J., Casalino, S., Mahajan, R., Watkins, N., Agaoglu, N. B., Manning, D. K., Barletta, J. A., Hornick, J. L., ... Ghazani, A. A. (2025). Advancing the Landscape of Clinical Actionability in Von Hippel–Lindau Syndrome: An Evidence-Based Framework from the INT²GRATE Oncology Consortium. Cancers, 17(13), 2173. https://doi.org/10.3390/cancers17132173